S.H.N. Financial Investments Ltd. - Aug 14, 2025 SCHEDULE 13G/A Report for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV)

Filing Manager: S.H.N. Financial Investments Ltd.
Reporting Manager: S.H.N. Financial Investments Ltd.
Security: Plus Therapeutics, Inc. Common Stock, $0.001 par value
Symbol: PSTV
Shares outstanding: 99.3M shares
Disclosed Ownership: 1.5M shares
Ownership: 1.51%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 06:52 PM
Date of event: Aug 14, 2025
Previous filing: Mar 18, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
S.H.N. Financial Investments Ltd.	1.51%	1.5M	1.5M	0	/s/ Nir Shamir	Nir Shamir, Chief Executive Officer